Quickly supply alternative strategic theme areas vis-a-vis B2C mindshare. Objectively repurpose stand-alone synergy via user-centric architectures.
- +32 3 689 85 38
- Technology Lane 82, 9052 Ghent Belgium
- info@gulliverbiomed.com
Quickly supply alternative strategic theme areas vis-a-vis B2C mindshare. Objectively repurpose stand-alone synergy via user-centric architectures.
Gulliver Biomed builds further on the expertise acquired in the field of immunomodulation. We aim to foster single domain antibody (sdAb) research in general and bring these powerful tools to the scientific community and private industry at large.
NANOBODY® antibodies, VHHs or single domain antibodies, afford many opportunies to the research community. They can reduce inherent problems of reproducibility experienced with conventional antibodies because their cDNAs are obtained following phage panning and they are 10 times smaller compared to regular antibodies.
We can provide you with these sophisticated biomaterials for your biochemical, biophysical, pharmaceutical, cell biological, (medical) imaging research needs. Peruse our catalogue or contact us to develop your own personal set of VHHs and stay on top of research. As you get accustomed to their flexibility, versatility and broad range of applications in vitro and in vivo, these unique antibodies will inspire you to envisage new uses and boost your work.
NANOBODY® compounds are registered trademarks of Ablynx N.V.